Clinical Scorecard: Evaluation of Visual and Refractive Outcomes Between Two Advanced Monofocal Intraocular Lenses
At a Glance
Category
Detail
Condition
Key Mechanisms
Enhanced monofocal IOLs designed to extend depth of focus and improve intermediate vision, as well as maintain contrast sensitivity.
Target Population
Care Setting
Key Highlights
Comparison of visual and refractive outcomes between Isopure 1.2.3 and Eyhance IOLs, focusing on specific metrics such as visual acuity and patient satisfaction.
Enhanced monofocal IOLs provide better intermediate vision than standard monofocal IOLs, with statistical significance.
Study conducted on Korean cataract patients with specific inclusion and exclusion criteria, ensuring a homogenous study population.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Evaluate postoperative visual acuities and refractive outcomes at 3 months follow-up, and consider additional assessments at 6 months.
Risks
Patient & Prescribing Data
Enhanced monofocal IOLs like ISP and EH can improve intermediate vision while minimizing dysphotopsia, with reported patient satisfaction rates.
Clinical Best Practices
Use biometric assessments for accurate IOL power calculations, and consider patient-specific factors in lens selection.
Follow postoperative care protocols with antibiotic and steroid drops, and schedule follow-up visits to monitor recovery.
